Veeva Systems Inc. (VEEV)
NYSE · Healthcare · Health Information Services
$283.45+3.70%as of Oct 6, 2026, 1:35 AM ET
- Market cap
- $45.9B
- P/E (trailing)
- 46.5
- Forward P/E
- 27.6
- 52-week range
- $148.05 – $310.50
- 52-week change
- −10.74%
- EPS (trailing)
- $6.10
- Analyst rating
- 2.0 Buy
- Next earnings
- Nov 25, 2026
Fiscal year to Jan 2026
- Revenue
- $3.2B (+16.34%)
- Net income
- $909M
- Operating margin
- 28.7%
- Diluted EPS
- $5.44
From the company’s annual report on SEC EDGAR.
About Veeva Systems Inc.
Veeva Systems Inc. provides cloud-based software for the life sciences industry in North America, Europe, the Asia Pacific, the Middle East, Africa, and Latin America. The company offers Veeva Commercial Cloud comprising Veeva Vault CRM Suite for pharmaceutical and biotechnology companies; Veeva Medical that provides source of medical content across multiple channels and geographies; Veeva PromoMats, an end-to-end content and digital asset management solution; and Veeva Crossix, an analytics platform for pharmaceutical brands. It also provides Veeva Data Cloud, such as Veeva OpenData, a customer reference data solution; Veeva Link, which provides deep data; Veeva Compass, which includes de-identified and longitudinal patient data; and Veeva CRM Pulse that provides access and multichannel engagement metrics.
Headquarters: Pleasanton, United States · 7,928 employees · veeva.com